Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Muscle Weakness in Critically Ill Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute respiratory failure requiring mechanical ventilation~Exclusion Criteria:~* Attending physician on service determines that patient too unstable to tolerate measurements~* Patient requires \> 15mcg/min norepinephrine or \> 15mg/kg/min of dopamine.~* Fraction of inspired oxygen \> 80% or positive end expiratory pressure \> 15 cm H20 requirements.~* Cardiac pacemaker or implanted defibrillator.~* Neuromuscular blocking agents delivered within 48 hours of preceding testing.~* Existing neuromuscular disease.~* Profound uncorrectable hypokalemia (\< 2.5) OR hypophosphatemia (\< 1.0)~* Acute lower extremity deep vein thrombosis~* Pregnancy~* Prisoner~* Institutionalized patient~* If primary attending determines that patient is terminal and will likely have care withdrawn within 7 days~* Do not resuscitate order~* Body mass index \> 40~* Patients requiring mechanical ventilation more than 4 days prior to study entry

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sham Treatment (Type: SHAM_COMPARATOR): Sham stimulation twice daily
- Active Treatment (Type: ACTIVE_COMPARATOR): The active treatment group will receive neuromuscular electrical stimulation to both quadriceps muscle for 30 minutes twice daily for a total of 14 treatments.

Based on this trial design, predict the completion outcome and termination type (if applicable).